65 results
Page 3 of 4
8-K
EX-1.1
lrkq3bhzsxyr
21 Sep 20
Entry into a Material Definitive Agreement
5:26pm
424B5
156l3 cze8338
21 Sep 20
Prospectus supplement for primary offering
5:02pm
424B5
0dkkjj1
17 Sep 20
Prospectus supplement for primary offering
5:25pm
424B5
4hd 6j69z
21 Nov 19
Prospectus supplement for primary offering
8:31am
424B5
3sz3df4g
19 Nov 19
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.1
3d4hsa 19c5kv
9 May 19
Checkpoint Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
5:13pm
10-K
EX-10.19
voyqsz0z
17 Mar 17
Annual report
12:00am
10-K
zn67hdyl5ffvw73
17 Mar 17
Annual report
12:00am
10-12G/A
p1y2dnm58t
19 Aug 16
Registration of securities (amended)
12:00am
10-12G/A
4o7u5efkkn86ni okgcn
29 Jul 16
Registration of securities (amended)
12:00am
10-12G
280 bd0nk1r
11 Jul 16
Registration of securities
12:00am
10-12G
EX-3.3
z9e377 ff
11 Jul 16
Registration of securities
12:00am
10-12G
EX-10
fap3979wz84w1
11 Jul 16
Registration of securities
12:00am
10-12G/A
p6mqmhhhhjixcd
16 May 16
Registration of securities (amended)
12:00am
10-12G/A
rvs4gj3kjfd 5t
27 Apr 16
Registration of securities (amended)
12:00am
10-12G
gv8mr7wm
24 Mar 16
Registration of securities
12:00am